HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chang-Jin Kim Selected Research

Cadherins (E-Cadherin)

7/2019Prognostic significance of IFITM1 expression and correlation with microvessel density and epithelial-mesenchymal transition signature in lung adenocarcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chang-Jin Kim Research Topics

Disease

14Neoplasms (Cancer)
03/2022 - 01/2002
8Colorectal Neoplasms (Colorectal Cancer)
03/2022 - 06/2011
5Uterine Cervical Neoplasms (Cancer of the Cervix)
05/2011 - 05/2010
4Carcinogenesis
03/2022 - 05/2010
3Carcinoma (Carcinomatosis)
06/2011 - 11/2007
2Lung Neoplasms (Lung Cancer)
02/2016 - 01/2016
2Persistent Infection
11/2012 - 04/2012
1Adenocarcinoma of Lung
07/2019
1Neoplasm Metastasis (Metastasis)
02/2016
1Adenocarcinoma
01/2016
1Infections
01/2016
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2016
1Meningitis
01/2013
1Papillary Thyroid Cancer
02/2012
1Hypoxia (Hypoxemia)
11/2007
1Colonic Neoplasms (Colon Cancer)
11/2007
1Corneal Neovascularization
02/2007
1Seizures (Absence Seizure)
04/2005

Drug/Important Bio-Agent (IBA)

5Biomarkers (Surrogate Marker)IBA
08/2020 - 06/2010
3Small Interfering RNA (siRNA)IBA
10/2020 - 07/2017
3Proteins (Proteins, Gene)FDA Link
01/2019 - 03/2005
3AgarIBA
12/2017 - 03/2011
2VimentinIBA
07/2019 - 05/2011
2Anti-Infective Agents (Microbicides)IBA
11/2012 - 04/2012
2Messenger RNA (mRNA)IBA
06/2011 - 05/2010
2Antineoplastic Agents (Antineoplastics)IBA
11/2007 - 03/2005
2Glucose (Dextrose)FDA LinkGeneric
11/2007 - 03/2005
1Tumor Biomarkers (Tumor Markers)IBA
03/2022
1Biological ProductsIBA
03/2022
1Polyamine OxidaseIBA
03/2022
1Histone ChaperonesIBA
10/2020
1MicroRNAs (MicroRNA)IBA
08/2020
1streptimidoneIBA
01/2020
1leu-13 antigenIBA
07/2019
1CateninsIBA
07/2019
1Cadherins (E-Cadherin)IBA
07/2019
1RNA (Ribonucleic Acid)IBA
01/2019
1alpha-DefensinsIBA
01/2019
1Tyrosine (L-Tyrosine)FDA Link
06/2018
1Protein Kinases (Protein Kinase)IBA
06/2018
1Karyopherins (Importin)IBA
12/2017
1Angiopoietin-2IBA
07/2017
1NADPH Oxidases (NAD(P)H oxidase)IBA
01/2017
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2017
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
02/2016
1ErbB Receptors (EGF Receptor)IBA
02/2016
1Tyrosine Kinase InhibitorsIBA
01/2016
1Anti-Bacterial Agents (Antibiotics)IBA
01/2016
1Polymyxin B (Aerosporin)FDA LinkGeneric
01/2016
1Polymyxins (Polymyxin)IBA
01/2016
1NetropsinIBA
01/2016
1Peptide Nucleic AcidsIBA
02/2012
1SurvivinIBA
06/2011
1MethyltransferasesIBA
01/2011
1Peptides (Polypeptides)IBA
01/2011
1Adenylyl Cyclases (Adenylyl Cyclase)IBA
01/2011
1A-Form DNA (A-DNA)IBA
01/2011
1Histone Deacetylase InhibitorsIBA
01/2011
1hydrogen sulfite (bisulfite)IBA
05/2010
1trioctyl phosphine oxide (TOPO)IBA
11/2007
1Type I DNA Topoisomerases (Topoisomerase I)IBA
11/2007
1PlicamycinFDA Link
11/2007
1Etoposide (VP 16)FDA LinkGeneric
11/2007
1embellistatinIBA
02/2007
1Glutamic Acid (Glutamate)FDA Link
04/2005
1Kainic Acid (Kainate)IBA
04/2005
1Endoplasmic Reticulum Chaperone BiPIBA
03/2005
15-demethylovalicinIBA
01/2002
1methionine aminopeptidase 2IBA
01/2002

Therapy/Procedure

1Adjuvant Chemotherapy
12/2017
1Therapeutics
01/2016
1Aftercare (After-Treatment)
01/2013